focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.00
Bid: 25.00
Ask: 27.00
Change: 0.50 (1.96%)
Spread: 2.00 (8.00%)
Open: 25.50
High: 26.00
Low: 25.50
Prev. Close: 25.50
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Mar 2012 16:30

RNS Number : 2021A
Rock Solid Images plc
27 March 2012
 



 

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached:

 Rock Solid Images plc

2. Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

 

 

Other (please specify):

3. Full name of person(s) subject to the

notification obligation:

Thalassa Holdings Ltd

4. Full name of shareholder(s) (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed or

reached:

27 March 2012

6. Date on which issuer notified:

27 March 2012

7. Threshold(s) that is/are crossed or

reached:

Above 1%

 

 

8. Notified details:

A: Voting rights attached to shares

Class/type

of shares

 

if possible using the ISIN CODE

 

Situation previousto the triggering

transaction

Resulting situation after the triggering transaction

Number of Shares

Number

of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares

6,000,000

6,000,000

6,342,322

6,342,422

4.01%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial

instrument

 

Expiration date

 

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial

instrument

 

Exercise price

 

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

 

Total (A+B+C)

Number of voting rights

% of voting rights

6,342,322

4.01

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

 

10. Name of the proxy holder:

11. Number of voting rights proxy holder

will cease to hold:

12. Date on which proxy holder will cease to

hold voting rights:

 

13. Additional information:

14. Contact name:

Duncan Soukup

15. Contact telephone number:

+33 6 78 63 26 89

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in sharesxxii

 

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

Contact address

(registered office for legal entities)

Phone number & email

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

 

C: Additional information

 

 

 

 

 

 

 

For notes on how to complete form TR-1 please see the FSA website.

 

FSA Version 2.1 updated May 2009

 

Notes to TRI Form

 

i This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

 

ii Either the full name of the legal entity or another method for identifying the issuer or underlying issuer provided it is reliable and accurate.

 

iii This should be the full name of (a) the shareholder; (b) the person acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to in DTR5.2.1 (a), or (d) the direct or indirect holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, or the direct or indirect holder of financial instruments having a similar economic effect to qualifying financial instruments, as appropriate.

 

In relation to the transactions referred to in points DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in DTR5.2.1 (b), the person that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in DTR 5.2,1 (c), the person holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and person lodging the collateral under these conditions;

 

- in the circumstances foreseen in DTR5.2.1(d), the person who has a life interest in shares if that person is entitled to exercise the voting rights attached to the shares and the person who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

rights; in the circumstances foreseen in DTR5.2,1 (g), the person that controls the voting

 

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

 

iv Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This should be the full name of the shareholder or holder of financial instruments who is the counterpart( to the natural person or legal entity referred to in DTR5.2.

 

v The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, the date of entering into an agreement.

 

The date on which a threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect (see DTR 5.1.1 R (3)). For passive crossings, the date when the corporate event took effect.

 

In the case of financial instruments with a similar economic effect to qualifying financial instruments, the date on which a threshold is reached or crossed is the date of entering into the agreement. In the case of reaching or crossing a threshold passively as a result of a change in a delta adjusted holding or due to a change in the total voting rights of the issuer, the date should be that when the delta adjustment occurs or the total voting rights change rather than the date at which the agreement was entered into.

 

vi Please refer to the situation disclosed in the previous notification, In case the situation prior to the triggering transaction was below 3%, please state `below 3%.

 

vii If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is less than 3%.

 

viii Direct and Indirect

 

ix In case of combined holdings of shares with voting rights attached 'direct holding' and voting rights `indirect holdings', please split the voting rights number and percentage into the direct and indirect columns-if there is no combined holdings, please leave the relevant box blank.

 

x If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

 

xi Voting rights attached to shares in respect of which the notifying party is a direct shareholder (DTR 5.1)

 

xii Voting rights held by the notifying party as an indirect shareholder (DTR 5.2.1)

 

xiii date of maturity / expiration of the financial instrument i.e. the date when the right to acquire shares ends.

 

xiv If the financial instrument has such a period-please specify the period- for example once every three months starting from the [date].

 

xv In case of notifying the aggregate of all voting rights deemed to be held as a result of holdings of instruments having a similar economic effect to (but not including) qualifying instruments on a nominal basis, please also provide the exercise price and either expiration date, or conversion period. If notifying on a nominal basis there is no requirement to then provide the delta-adjusted figures as well.

 

xvi In case of notifying the aggregate of all voting rights deemed to be held as a result of holdings of instruments having a similar economic effect to (but not including) qualifying instruments on a delta-adjusted basis, please provide the expiration date/conversion period as appropriate.

 

xvii Expiration date of the financial instrument with a similar economic effect to a qualifying financial instrument i.e. the date when the instrument is due to be settled.

 

xix If the financial instrument has a conversion/settlement period-please specify the period- for example once every three months starting from the [date].

 

xix Nominal and delta-adjusted basis (transitional period to run until 31 December 2009)

 

xx If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

 

xxi The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held, or deemed to be held, by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

 

xxii This annex is only to be filed with the competent authority.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUMPWUPPGAM
Date   Source Headline
30th Apr 20243:40 pmEQSThalassa Holdings Ltd:
30th Apr 20243:33 pmEQSThalassa Holdings Ltd: Annual Financial Report
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.